Jamie Freedman

Instil Bio Chief Medical Officer Jamie Freedman, MD, PhD [Photo: LinkedIn]

Instil Bio Appoints ‘Seasoned’ Biopharma Exec as Chief Medical Officer

by | Jun 5, 2025
Dallas' Instil Bio said that Jamie Freedman has extensive experience in oncology drug development and other therapeutic areas, along with a track record of leading programs through all phases of development, regulatory approval, and commercialization.
MORE►
A Special Thank you to our sponsors

Dallas Innovates is owned by the Dallas Regional Chamber. Editorial operations are led independently by Lawley Head Media.

© Copyright 2026 | All rights reserved.

Business

Creative

Education

Impact

Invention

Startup

Our Sponsors

Our Partners